Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses

Cancer Causes and Control

Volumn 28, Issue 5, 2017, Pages 437-445

  Poole, Elizabeth M ^a   Lin, Wayne T ^a   Kvaskoff, Marina ^a,b   De Vivo, Immaculata ^a,c   Terry, Kathryn L ^a,c   Missmer, Stacey A ^a,c,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b INSERM   (France)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Endometrial cancer; Endometriosis; Ovarian cancer

Indexed keywords

ADULT; ARTICLE; CANCER RISK; COHORT ANALYSIS; CONFOUNDING VARIABLE; CONTROLLED STUDY; DELAYED DIAGNOSIS; DISEASE ASSOCIATION; ENDOMETRIOSIS; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; LAPAROSCOPY; MAJOR CLINICAL STUDY; NURSE; OVARY CANCER; PATIENT-REPORTED OUTCOME; PROSPECTIVE STUDY; RISK FACTOR; UNITED STATES; COMPLICATION; ENDOMETRIAL NEOPLASMS; MIDDLE AGED; OVARIAN NEOPLASMS; PREVALENCE; RISK;

ADULT; ENDOMETRIAL NEOPLASMS; ENDOMETRIOSIS; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PREVALENCE; PROSPECTIVE STUDIES; RISK;

EID: 85015239436     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-017-0856-4     Document Type: Article

References (43)

1. Giudice LC (2010) Clinical practice. Endometriosis. N Engl J Med 362:2389–2398
2. Burney RO, Giudice LC (2012) Pathogenesis and pathophysiology of endometriosis. Fertil Steril 98:511–519
3. Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Marshall LM, Hunter DJ (2004) Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol 160:784–796
4. Brinton LA, Westhoff CL, Scoccia B et al (2005) Causes of infertility as predictors of subsequent cancer risk. Epidemiology 16:500–507
5. Brinton LA, Sakoda LC, Sherman ME et al (2005) Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer epidemiology, biomarkers and prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive. Int Soc Cell 14:2929–2935
6. Kobayashi H, Sumimoto K, Moniwa N et al (2007) Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol Cancer 17:37–43
7. Pearce CL, Templeman C, Rossing MA et al (2012) Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies. Lancet Oncol 13:385–394
8. Buis CC, van Leeuwen FE, Mooij TM, Burger CW, Group OP (2013) Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis. Hum Reprod 28:3358–3369
9. Kvaskoff M, Mu F, Terry KL et al (2015) Endometriosis: a high-risk population for major chronic diseases? Hum Reprod Update 21(4):500–516
10. Lee WL, Chang WH, Wang KC et al (2015) The risk of epithelial ovarian cancer of women with endometriosis may be varied greatly if diagnostic criteria are different: a nationwide population-based cohort study. Medicine (Baltimore) 94:e1633
11. Mogensen JB, Kjaer SK, Mellemkjaer L, Jensen A (2016) Endometriosis and risks for ovarian, endometrial and breast cancers: a nationwide cohort study. Gynecol Oncol 143:87–92
12. de Boer EJ, den Tonkelaar I, Burger CW, van Leeuwen FE, Group OP (2005) Validity of self-reported causes of subfertility. Am J Epidemiol 161:978–986
13. Nnoaham KE, Hummelshoj L, Webster P et al (2011) Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril 96(366–73):e8
14. Borgfeldt C, Andolf E (2004) Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis. Acta Obstet Gynecol Scand 83:395–400
15. Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A (1997) Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 176:572–579
16. Melin A, Sparen P, Persson I, Bergqvist A (2006) Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod 21:1237–1242
17. Munksgaard PS, Blaakaer J (2011) The association between endometriosis and gynecological cancers and breast cancer: a review of epidemiological data. Gynecol Oncol 123:157–163
18. Rowlands IJ, Nagle CM, Spurdle AB, Webb PM, Australian National Endometrial Cancer Study G, Australian Ovarian Cancer Study G (2011) Gynecological conditions and the risk of endometrial cancer. Gynecol Oncol 123: 537–541
19. Zucchetto A, Serraino D, Polesel J et al (2009) Hormone-related factors and gynecological conditions in relation to endometrial cancer risk. Eur J Cancer Prev Off J Eur Cancer Prev Organ 18:316–321
20. Kurman RJ, Shih Ie M (2011) Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer–shifting the paradigm. Hum Pathol 42:918–931
21. McConechy MK, Anglesio MS, Kalloger SE et al (2011) Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas. J Pathol 223:567–573
22. McConechy MK, Ding J, Senz J et al (2014) Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles. Mod Pathol 27:128–134
23. Rockhill B, Willett WC, Hunter DJ et al (1998) Physical activity and breast cancer risk in a cohort of young women. J Natl Cancer Inst 90:1155–1160
24. Hosmer DW, Lemeshow S (1999) Applied survival analysis: regression modeling of time to event data. Wiley, New York
25. Olson JE, Cerhan JR, Janney CA, Anderson KE, Vachon CM, Sellers TA (2002) Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women’s Health Study. Cancer 94:1612–1618
26. Melin A, Sparen P, Bergqvist A (2007) The risk of cancer and the role of parity among women with endometriosis. Hum Reprod 22:3021–3026
27. Venn A, Watson L, Bruinsma F, Giles G, Healy D (1999) Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 354:1586–1590
28. Kim JJ, Kurita T, Bulun SE (2013) Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev 34:130–162
29. Ness RB (2003) Endometriosis and ovarian cancer: thoughts on shared pathophysiology. Am J Obstet Gynecol 189:280–294
30. Nezhat F, Datta MS, Hanson V, Pejovic T, Nezhat C, Nezhat C (2008) The relationship of endometriosis and ovarian malignancy: a review. Fertil Steril 90:1559–1570
31. Maccio A, Madeddu C (2012) Inflammation and ovarian cancer. Cytokine 58:133–147
32. Lee AW, Templeman C, Stram DA et al (2015) Evidence of a genetic link between endometriosis and ovarian cancer. Fertil Steril 105(1):35–43
33. Lu Y, Cuellar-Partida G, Painter JN et al (2015) Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Hum Mol Genet 24:5955–5964
34. Sato N, Tsunoda H, Nishida M et al (2000) Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 60:7052–7056
35. Dinulescu DM, Ince TA, Quade BJ, Shafer SA, Crowley D, Jacks T (2005) Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med 11:63–70
36. Wiegand KC, Shah SP, Al-Agha OM et al (2010) ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 363:1532–1543
37. Holt VL, Weiss NS (2000) Recommendations for the design of epidemiologic studies of endometriosis. Epidemiology 11:654–659
38. Felix AS, Weissfeld JL, Stone RA et al (2010) Factors associated with type I and type II endometrial cancer. Cancer Causes Control 21:1851–1856
39. Brasky TM, Felix AS, Cohn DE et al (2017) Nonsteroidal anti-inflammatory drugs and endometrial carcinoma mortality and recurrence. J Natl Cancer Inst 109(3):djw251. doi:10.1093/jnci/djw251
40. Brinton LA, Felix AS, McMeekin DS et al (2013) Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial. Gynecol Oncol 129:277–284
41. Brinton LA, Trabert B, Anderson GL et al (2016) Serum estrogens and estrogen metabolites and endometrial cancer risk among postmenopausal women. Cancer epidemiology, biomarkers and prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive. Int Soc Cell 25:1081–1089
42. Setiawan VW, Yang HP, Pike MC et al (2013) Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 31:2607–2618
43. Uccella S, Mariani A, Wang AH et al (2013) Intake of coffee, caffeine and other methylxanthines and risk of type I vs type II endometrial cancer. Br J Cancer 109:1908–1913